Febuxostat Dosage and Administration for Gout Management

Initial Dosing and Titration

• Start febuxostat at 40 mg once daily, then increase to 80 mg daily after 2 weeks if serum urate levels remain elevated, with the maximum FDA-approved dose being 80 mg/day in the United States 1, 2
• The American College of Rheumatology recommends titrating dose to achieve serum urate <6 mg/dL using a treat-to-target strategy 1, 2

Dose Escalation for Refractory Disease

• For patients with active disease refractory to standard oral therapy, febuxostat may be increased to 120 mg daily, a dose approved in many countries outside the USA 3, 4

Mandatory Flare Prophylaxis

• Always initiate concomitant anti-inflammatory prophylaxis when starting febuxostat, using colchicine, NSAIDs, or prednisone/prednisolone 1, 2
• Continue prophylaxis for 3-6 months after initiating therapy, with ongoing evaluation and extended prophylaxis if flares persist 1, 2

Treatment Target and Monitoring

• Titrate dose to achieve serum urate <6 mg/dL using a treat-to-target strategy 1, 2
• For patients with severe gout, consider a lower target of <5 mg/dL until crystal dissolution is complete 7

Clinical Context and Positioning

• The 2020 American College of Rheumatology guidelines strongly recommend allopurinol over febuxostat as first-line therapy for all patients with gout 1, 2
• At 80 mg daily, febuxostat demonstrates greater urate-lowering efficacy than allopurinol 300 mg daily in head-to-head trials 6

Common Pitfalls to Avoid

• Do not start at higher doses (80 mg) initially, as this increases the risk of gout flares during initiation 1, 2
• Never initiate febuxostat without anti-inflammatory prophylaxis, as this significantly increases flare risk 1, 2